HighCape Partners

HighCape Partners is a growth equity firm that invests in commercial-stage life sciences companies. The firm applies decades of combined investment and operational experience to help transform its portfolio companies into sustainable businesses with multiple exit alternatives. HighCape Partners focuses on companies that are developing innovative therapeutics, diagnostics, and medical devices, providing strategic guidance and operational support to foster entrepreneurship and deliver value to the healthcare system.

Established in 2013, HighCape Partners has invested in several companies, including Wellinks, a developer of connected medical devices for respiratory wellness; TELA Bio, a surgical reconstruction company; and Aziyo Biologics, a regenerative medicine company. The firm's investment philosophy centers on providing strategic guidance, operational support, and access to a broad network of industry contacts to help portfolio companies achieve their objectives. Notable achievements include successful exits through acquisitions and public offerings, demonstrating the firm's ability to identify and nurture high-impact companies.

HighCape Partners differentiates itself through its specialized focus on life sciences, its hands-on approach to portfolio management, and its commitment to fostering long-term partnerships with entrepreneurs. The firm's team leverages extensive experience in founding, financing, and leading life sciences companies across various industry segments, enabling them to provide timely and valued insights to their portfolio companies. This collaborative approach aims to enhance commercial and operational strategies, expand talent and resources, and support the growth and success of their investments.